New Science Ventures
Startup rounds since 2012 with a New Science Ventures investor on the board, and the firm's own fund filings.
Raises
30
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Glydways, Inc.$60M
- Glydways, Inc.$101M
- Phase Four, Inc.$12.9M
- Ferric, Inc.$32.1M
- Pakal Technologies, Inc.$1.67M
- ABL Space Systems Co$40.6M
- Glydways, Inc.$46.8M
- Vascular Therapies Inc$24M
- ABL Space Systems Co$202M
- Pakal Technologies, Inc.$6.94M
- Phase Four, Inc.$5.52M
- Svelte Medical Systems Inc$5.45M
- Acuity Link Corp.$620K
- Vascular Therapies Inc$7.38M
- Light Sciences Oncology Inc$2.02M
- PerceptiMed, Inc.$2.07M
- Vascular Therapies Inc$12.4M
- Svelte Medical Systems Inc$3M
- Svelte Medical Systems Inc$12.3M
- Ralexar Therapeutics, Inc.$4.15M
- Vascular Therapies Inc$31M
- Svelte Medical Systems Inc$50.4M
- Directed Sensing Inc.$2M
- Juventas Therapeutics Inc$7.39M
- Alexar Therapeutics, Inc.$10.6M
- Silicon Space Technology Corp$1.6M
- Silicon Space Technology Corp$3.34M
- Bioscale Inc$5.26M
- Silicon Space Technology Corp$2.5M
- Juventas Therapeutics Inc$12M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 0 |
| 2025 | 2 | 0 |
| 2024 | 2 | — |
| 2023 | 2 | — |
| 2022 | 1 | — |
| 2021 | 4 | — |
| 2020 | 1 | — |
| 2019 | 2 | — |
| 2018 | 2 | — |
| 2017 | 3 | — |
| 2016 | 3 | — |
| 2015 | 2 | — |
| 2014 | 2 | — |
| 2012 | 3 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| New Science Ventures Fund III, L.P. | 23 Jul 2014 | $100M | $25.4M |
| New Science Ventures Fund III (Offshore), L.P. | 23 Jul 2014 | $100M | $10.3M |
Listed because a New Science Ventures fund's filing names a director of each company. A name match is not a verified identity.